Literature DB >> 1348943

Correlation between kinetics of soluble CD4 interactions with HIV-1-Env-expressing cells and inhibition of syncytia formation: implications for mechanisms of cell fusion and therapy for AIDS.

D S Dimitrov1, K Hillman, J Manischewitz, R Blumenthal, H Golding.   

Abstract

OBJECTIVES: To study the kinetics of the interactions between soluble (s) CD4 and HIV-1-Env-expressing cells in relation to subsequent events leading to cell fusion and inhibition of syncytia formation.
DESIGN: Vaccinia-HIV-1 (Env)-infected CD4- T-cells were used to study the kinetics of sCD4-gp120/41 interactions and syncytia formation (with CD4+ T-cells) under identical conditions.
METHODS: sCD4 association and dissociation rates for HIV-1-Env-expressing cells, and quantification of sCD4-induced gp120 shedding was determined by a quantitative flow cytometry assay. Syncytia inhibition was measured in the continuous presence of sCD4, or after washing of HIV-1-Env-expressing cells following pre-incubation with sCD4.
RESULTS: The kinetics of syncytia inhibition correlated with sCD4 binding when sCD4 was maintained during the culture. When Env-expressing cells, which had been pre-incubated with sCD4, were washed to remove unbound sCD4, no syncytia formation inhibition was observed, even following sCD4-induced shedding of greater than 50% of surface gp120 molecules.
CONCLUSIONS: The lack of syncytia inhibition seen after removal of unbound sCD4, even after pre-incubation of cells under saturation and gp120 shedding conditions, indicated that sufficient numbers of fusogenic molecules remained on the sCD4-treated cells. In addition, fast dissociation of pre-bound sCD4 occurred in culture. These results are important for understanding HIV-1-Env-mediated cell fusion and AIDS therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348943     DOI: 10.1097/00002030-199203000-00001

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  11 in total

1.  Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.

Authors:  U O'Doherty; W J Swiggard; M H Malim
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Binding kinetics of ecotropic (Moloney) murine leukemia retrovirus with NIH 3T3 cells.

Authors:  H Yu; N Soong; W F Anderson
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

3.  Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer.

Authors:  V Litwin; K A Nagashima; A M Ryder; C H Chang; J M Carver; W C Olson; M Alizon; K W Hasel; P J Maddon; G P Allaway
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

4.  Photoinactivation and kinetics of membrane fusion mediated by the human immunodeficiency virus type 1 envelope glycoprotein.

Authors:  D S Dimitrov; R Blumenthal
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

5.  Calcium ions are required for cell fusion mediated by the CD4-human immunodeficiency virus type 1 envelope glycoprotein interaction.

Authors:  D S Dimitrov; C C Broder; E A Berger; R Blumenthal
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

6.  Cell fusion mediated by interaction of a hybrid CD4.CD8 molecule with the human immunodeficiency virus type 1 envelope glycoprotein does occur after a long lag time.

Authors:  H Golding; R Blumenthal; J Manischewitz; D R Littman; D S Dimitrov
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

7.  Infection by HIV-1 blocked by binding of dextrin 2-sulphate to the cell surface of activated human peripheral blood mononuclear cells and cultured T-cells.

Authors:  S Shaunak; N J Gooderham; R J Edwards; N Payvandi; C M Javan; N Baggett; J MacDermot; J N Weber; D S Davies
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

8.  Brucella abortus conjugated with a gp120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type 1 induces neutralizing anti-HIV antibodies, and the V3-B. abortus conjugate is effective even after CD4+ T-cell depletion.

Authors:  B Golding; J Inman; P Highet; R Blackburn; J Manischewitz; N Blyveis; R D Angus; H Golding
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

9.  Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation.

Authors:  P Poignard; T Fouts; D Naniche; J P Moore; Q J Sattentau
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

10.  A point mutation in the binding subunit of a retroviral envelope protein arrests virus entry at hemifusion.

Authors:  Tatiana Zavorotinskaya; Zhaohui Qian; John Franks; Lorraine M Albritton
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.